{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T20:40:30Z","timestamp":1783370430748,"version":"3.54.6"},"reference-count":64,"publisher":"The Korean Association for the Study of the Liver","issue":"4","license":[{"start":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T00:00:00Z","timestamp":1693267200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"funder":[{"DOI":"10.13039\/501100003645","name":"National Cancer Center","doi-asserted-by":"publisher","award":["2110351"],"award-info":[{"award-number":["2110351"]}],"id":[{"id":"10.13039\/501100003645","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["e-cmh.org"],"crossmark-restriction":true},"short-container-title":["Clin Mol Hepatol"],"published-print":{"date-parts":[[2023,10,1]]},"abstract":"<jats:p>Hepatocellular carcinoma (HCC) is a leading cause of cancer-related death, and external beam radiation therapy has emerged as a promising approach for managing HCC. Proton beam therapy (PBT) offers dosimetric advantages over X-ray therapy, with superior physical properties known as the Bragg peak. PBT holds promise for reducing hepatotoxicity and allowing safe dose-escalation to the tumor. It has been tried in various clinical conditions and has shown promising local tumor control and survival outcomes. A recent phase III trial demonstrated the non-inferiority of PBT in local tumor control compared to current standard radiofrequency ablation in early-stage HCC. PBT also tended to show more favorable outcomes compared to transarterial chemoembolization in the intermediate stage, and has proven effective in-field disease control and safe toxicity profiles in advanced HCC. In this review, we discuss the rationale, clinical studies, optimal indication, and future directions of PBT in HCC treatment.<\/jats:p>","DOI":"10.3350\/cmh.2023.0274","type":"journal-article","created":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T07:50:26Z","timestamp":1693295426000},"page":"958-968","update-policy":"https:\/\/doi.org\/10.3350\/crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Current evidence and the potential role of proton beam therapy for hepatocellular carcinoma"],"prefix":"10.3350","volume":"29","author":[{"given":"Sung Uk","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8413-3385","authenticated-orcid":true,"given":"Tae Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1902","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/s0360-3016(02)02846-8"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(94)00418-k"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.03.019"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2010.10.014"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.semradonc.2005.04.005"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2006.08.015"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.semradonc.2012.11.003"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/1748-717x-8-48"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s00066-021-01854-6"},{"key":"ref11","first-page":"3201","volume-title":"[Dose distributions of proton beam therapy for hepatocellular carcinoma: a comparative study of treatment planning with 3D-conformal radiation therapy or intensity-modulated radiation therapy]","author":"Li","year":"2009"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.meddos.2007.04.008"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3109\/0284186x.2015.1009637"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1118\/1.3187229"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1078\/0939-3889-00217"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.adro.2021.100675"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1177\/0300891620937809"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2020.02.019"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.semradonc.2020.02.007"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2005.11.043"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.prro.2018.04.012"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2017.03.004"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-020-01605-4"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2014.11.033"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.21037\/jgo.2019.08.03"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/s0360-3016(00)00568-x"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.26134"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2004.01.032"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.prro.2015.01.004"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.phro.2018.11.004"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00457"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.prro.2015.02.007"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1007\/s00066-006-1564-2"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1007122"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(09)60381-0"},{"key":"ref36","first-page":"820","volume-title":"Clinical outcomes of a cohort series of patients with hepatocellular carcinoma in a hepatitis B virus-endemic area","author":"Kwak","year":"2014"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.3350\/kjhep.2009.15.3.391"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2005.00.620"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-04-1350"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2007.09.056"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2008.10.073"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2010.03.015"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.4143\/crt.2013.218"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2015.64.2710"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2018.10.041"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.23428"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11020230"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00542"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.09.026"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2021.03.049"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1016\/s1051-0443(98)70307-0"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.34965"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1111\/cas.13145"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14184445"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2022.0294"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1915745"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2017.5847"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1200\/jco.18.02184"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21237"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1007\/s00066-009-2020-x"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1007\/s00066-014-0604-6"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2016.12.014"},{"key":"ref63","first-page":"1606","volume-title":"Proton beam radiotherapy combined with anti-PD1\/PDL1 immune checkpoint inhibitors for advanced hepatocellular carcinoma","author":"Su","year":"2022"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.829708"}],"container-title":["Clinical and Molecular Hepatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/e-cmh.org\/upload\/pdf\/cmh-2023-0274.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/e-cmh.org\/journal\/view.php?doi=10.3350\/cmh.2023.0274","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/e-cmh.org\/upload\/pdf\/cmh-2023-0274.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T06:20:58Z","timestamp":1697005258000},"score":1,"resource":{"primary":{"URL":"http:\/\/e-cmh.org\/journal\/view.php?doi=10.3350\/cmh.2023.0274"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,1]]},"references-count":64,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,10]]}},"URL":"https:\/\/doi.org\/10.3350\/cmh.2023.0274","relation":{},"ISSN":["2287-2728","2287-285X"],"issn-type":[{"value":"2287-2728","type":"print"},{"value":"2287-285X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,1]]},"assertion":[{"value":"2023-07-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-08-27","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-08-29","order":2,"name":"published","label":"Published online","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-10-01","order":3,"name":"published","label":"Print publication","group":{"name":"publication_history","label":"Publication History"}}]}}